A new analysis has suggested that an inflammatory response may be a crucial and modifiable determinant of disability accrual in progressive-onset multiple sclerosis.
Clyde E. Markowitz, MD, and Patricia K. Coyle, MD, provide insight on the 2017 revisions to the McDonald criteria that will optimize the management of patients with multiple sclerosis.

SAP Partner Banner